| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.5065 | 34 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.1135 | 45 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.3954 | 43 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.0719 | 22 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.839 | 17 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.5533 | 60 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.5416 | 20 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 61.1306 | 65 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.3675 | 60 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.9776 | 54 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.3775 | 43 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.0427 | 49 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.8036 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.6642 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 60.4132 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 57.286 | 62 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.2926 | 58 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.4864 | 62 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 39.771 | 6 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.566 | 43 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.2436 | 42 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.8679 | 31 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.9161 | 48 |